Immatics Future Growth
Future criteria checks 1/6
Immatics's earnings are forecast to decline at 4.9% per annum while its annual revenue is expected to grow at 18.1% per year. EPS is expected to grow by 5.3% per annum.
Key information
-4.9%
Earnings growth rate
5.3%
EPS growth rate
| Biotechs earnings growth | 21.2% |
| Revenue growth rate | 18.1% |
| Future return on equity | n/a |
| Analyst coverage | Good |
| Last updated | 19 Apr 2024 |
Recent future growth updates
Recent updates
We're Hopeful That Immatics (NASDAQ:IMTX) Will Use Its Cash Wisely
Sep 26
We're Hopeful That Immatics (NASDAQ:IMTX) Will Use Its Cash Wisely
Jun 12Immatics launches $110M stock offering
Oct 10Cancer immunotherapy biotech Immatics up 18% on 4x normal volume
Jul 19Here's Why We're Watching Immatics' (NASDAQ:IMTX) Cash Burn Situation
Jan 29Analysts' Revenue Estimates For Immatics N.V. (NASDAQ:IMTX) Are Surging Higher
Dec 16Immatics N.V. (NASDAQ:IMTX) Analysts Are Pretty Bullish On The Stock After Recent Results
Apr 01What Is The Ownership Structure Like For Immatics N.V. (NASDAQ:IMTX)?
Jan 18Immatics reports Q3 results
Dec 02Immatics (IMTX) Investor Presentation - Slideshow
Nov 13Earnings and Revenue Growth Forecasts
| Date | Revenue | Earnings | Free Cash Flow | Cash from Op | Avg. No. Analysts |
|---|---|---|---|---|---|
| 12/31/2026 | 50 | -171 | -144 | N/A | 4 |
| 12/31/2025 | 59 | -138 | -128 | N/A | 6 |
| 12/31/2024 | 60 | -131 | -117 | N/A | 7 |
| 12/31/2023 | 54 | -97 | -13 | 18 | N/A |
| 9/30/2023 | 76 | -84 | -117 | -92 | N/A |
| 6/30/2023 | 85 | -79 | -105 | -86 | N/A |
| 3/31/2023 | 80 | -68 | -40 | -31 | N/A |
| 12/31/2022 | 173 | 38 | 94 | 100 | N/A |
| 9/30/2022 | 151 | 34 | 97 | 102 | N/A |
| 6/30/2022 | 142 | 28 | 113 | 119 | N/A |
| 3/31/2022 | 130 | 15 | 38 | 44 | N/A |
| 12/31/2021 | 35 | -93 | -90 | -85 | N/A |
| 9/30/2021 | 28 | -95 | -86 | -81 | N/A |
| 6/30/2021 | 30 | -231 | -133 | -127 | N/A |
| 3/31/2021 | 32 | -226 | -97 | -91 | N/A |
| 12/31/2020 | 31 | -211 | -88 | -81 | N/A |
| 9/30/2020 | 26 | -208 | -38 | -31 | N/A |
| 6/30/2020 | 23 | -49 | 75 | 81 | N/A |
| 3/31/2020 | 22 | -34 | 55 | 60 | N/A |
| 12/31/2019 | 18 | -32 | 69 | 71 | N/A |
| 12/31/2018 | 4 | -31 | 20 | 21 | N/A |
Analyst Future Growth Forecasts
Earnings vs Savings Rate: IMTX is forecast to remain unprofitable over the next 3 years.
Earnings vs Market: IMTX is forecast to remain unprofitable over the next 3 years.
High Growth Earnings: IMTX is forecast to remain unprofitable over the next 3 years.
Revenue vs Market: IMTX's revenue (18.1% per year) is forecast to grow faster than the US market (8% per year).
High Growth Revenue: IMTX's revenue (18.1% per year) is forecast to grow slower than 20% per year.
Earnings per Share Growth Forecasts
Future Return on Equity
Future ROE: Insufficient data to determine if IMTX's Return on Equity is forecast to be high in 3 years time